Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
1.300
-0.070 (-5.11%)
Jan 8, 2025, 4:00 PM EST - Market closed
Mersana Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$6.00
Upside
+361.54%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +284.62% | Aug 27, 2024 |
| Baird | Baird | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +130.77% | Aug 14, 2024 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $5 | Sell → Hold | Upgrades | $5 | +284.62% | Mar 19, 2024 |
| Wedbush | Wedbush | Hold → Buy Upgrades $2 → $7 | Hold → Buy | Upgrades | $2 → $7 | +438.46% | Feb 29, 2024 |
| Truist Securities | Truist Securities | Hold → Strong Buy Upgrades $9 | Hold → Strong Buy | Upgrades | $9 | +592.31% | Feb 29, 2024 |
| Baird | Baird | Hold Maintains $1 → $5 | Hold | Maintains | $1 → $5 | +284.62% | Feb 29, 2024 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $7 | Hold → Strong Buy | Upgrades | $7 | +438.46% | Feb 29, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $1 → $5 | Hold → Strong Buy | Upgrades | $1 → $5 | +284.62% | Dec 4, 2023 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $10 → $1 | Strong Buy → Hold | Downgrades | $10 → $1 | -23.08% | Jul 28, 2023 |
| Baird | Baird | Buy → Hold Downgrades $7 → $1 | Buy → Hold | Downgrades | $7 → $1 | -23.08% | Jul 28, 2023 |
| Wedbush | Wedbush | Buy → Hold Downgrades $12 → $2 | Buy → Hold | Downgrades | $12 → $2 | +53.85% | Jul 27, 2023 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 27, 2023 |
| Citigroup | Citigroup | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +669.23% | Jun 16, 2023 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $11 → $5 | Buy → Hold | Downgrades | $11 → $5 | +284.62% | Jun 16, 2023 |
| Guggenheim | Guggenheim | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +976.92% | Jun 15, 2023 |
| Citigroup | Citigroup | Strong Buy Maintains $12 → $15 | Strong Buy | Maintains | $12 → $15 | +1,053.85% | May 11, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.